193. Deputy Billy Kelleher asked the Minister for Health the average sums the Health Service Executive paid for a typical course of fidaxomicin, vancomycin and other drugs used for persons infected with clostridium difficile and methicillin resistant staphylococcus aureus, MRSA, in hospitals under its control, by patient, in each of the years 2011 to 2016 to date, in tabular form; and if he will make a statement on the matter. [12325/16]

Summary

193. Deputy Billy Kelleher asked the Minister for Health the average sums the Health Service Executive paid for a typical course of fidaxomicin, vancomycin and other drugs used for persons infected with clostridium difficile and methicillin resistant staphylococcus aureus, MRSA, in hospitals under its control, by patient, in each of the years 2011 to 2016 to date, in tabular form; and if he will make a statement on the matter. [12325/16]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 26 May 2016

   Medicinal Products Expenditure

   193. Deputy Billy Kelleher asked the Minister for Health the average sums the Health Service Executive paid for a typical course of fidaxomicin, vancomycin and other drugs used for persons infected with clostridium difficile and methicillin resistant staphylococcus aureus, MRSA, in hospitals under its control, by patient, in each of the years 2011 to 2016 to date, in tabular form; and if he will make a statement on the matter. [12325/16]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Expenditure

  xml · EN · 26 May 2016

  ViewDownloadOpen at official source

Sponsors

• Kelleher, Billy. · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.